Natalie Marie Asborno, NP
Nurse Practitioner · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 4
- Since medical school
- 12 years
- Graduated 2014
Offices
4 locations · UCSF Medical Group Business Services · 1,533 clinicians in this group
Looking this up.
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Natalie Marie Asborno’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$9,152
Medicare paid this office $9,152 for 68 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 51 | $6,863 | $101 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 30 | $490 | $13 |
Who their Medicare patients are
68 Original Medicare patients in 2024. Average age 69 · Also on Medicaid 38% · Health risk score 3.73. Sicker patients than 9 in 10 peers; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 65% · Cancer 59% · Chronic kidney disease 35% · Atrial fibrillation 26% · Coronary heart disease 24% · Diabetes 22% · Depression 19%.
The office billed $70,686, Medicare allowed $12,325 and paid $9,152; for 131 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 68 | 131 | 69 | 3.73 | $70,686 | $9,152 |
| 2023 | 30 | 194 | 61 | 5.27 | $118,236 | $15,352 |
| 2022 | 45 | 247 | 56 | 9.16 | $166,345 | $22,575 |
| 2021 | 26 | 149 | 61 | 9.48 | $99,069 | $13,815 |
| 2018 | 546 | 833 | 74 | 2.18 | $282,927 | $66,634 |
| 2017 | 501 | 923 | 72 | 2.47 | $302,996 | $70,058 |
| 2016 | 260 | 574 | 75 | 2.52 | $194,761 | $39,243 |
| 2015 | 194 | 474 | 76 | 3.20 | $171,589 | $32,799 |
| 2014 | 85 | 171 | 75 | 2.56 | $64,910 | $12,290 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Long return visit (40+ min) | 21 | $7,900 | $107 |
| Return visit (30+ min) | 12 | $1,896 | $65 |
2022: 2 services
| Long return visit (40+ min) | 42 | $15,168 | $107 |
| Return visit (30+ min) | 31 | $6,948 | $72 |
2021: 2 services
| Long return visit (40+ min) | 22 | $7,931 | $113 |
| Return visit (30+ min) | 23 | $5,780 | $75 |
2018: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 241 | $28,631 | $80 |
| Hospital discharge day management, more than 30 minutes | 121 | $10,219 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $6,487 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 73 | $5,182 | $56 |
| Hospital observation care on day of discharge | 88 | $4,925 | $55 |
| Initial hospital observation care per day, typically 70 minutes | 23 | $3,212 | $140 |
| Follow-up observation care per day, typically 35 minutes | 34 | $2,808 | $76 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,126 | $106 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $944 | $79 |
2017: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 323 | $42,552 | $74 |
| Hospital discharge day management, more than 30 minutes | 155 | $11,669 | $75 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,178 | $144 |
| Initial hospital observation care per day, typically 70 minutes | 25 | $3,173 | $127 |
| Hospital observation care on day of discharge | 50 | $2,604 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $2,568 | $51 |
| Follow-up observation care per day, typically 35 minutes | 21 | $1,645 | $75 |
2016: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $12,751 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 103 | $12,239 | $55 |
| Hospital discharge day management, more than 30 minutes | 70 | $5,725 | $80 |
| Hospital discharge day management, 30 minutes or less | 44 | $2,455 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,126 | $152 |
| Hospital observation care on day of discharge | 22 | $1,210 | $55 |
2015: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 115 | $14,081 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $4,632 | $77 |
| Hospital discharge day management, more than 30 minutes | 33 | $2,978 | $83 |
| Initial hospital observation care per day, typically 70 minutes | 18 | $2,682 | $141 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,676 | $157 |
| Hospital discharge day management, 30 minutes or less | 24 | $1,358 | $57 |
| Hospital observation care on day of discharge | 20 | $1,128 | $56 |
| Follow-up observation care per day, typically 25 minutes | 17 | $1,120 | $56 |
2014: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $4,008 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,462 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $2,261 | $78 |
| Hospital discharge day management, 30 minutes or less | 13 | $766 | $55 |
Drugs they prescribed that Part D paid
$129,646
Pharmacies billed $129,646 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
138 generic and 39 brand-name prescriptions · $129,646 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 20 | $13,205 | $660 |
| Mycophenolate Mofetil | 12 | $399 | $33 |
| Amlodipine Besylate | 18 | $107 | $6 |
Year by year
| 2024 | 177 | 74 | None | 22% | $129,646 |
| 2023 | 393 | 77 | None | None | $136,994 |
| 2022 | 423 | 82 | 0% (0) | 17% | $80,456 |
| 2021 | 603 | 110 | None | 17% | $103,544 |
| 2020 | 776 | 96 | 2% (16) | 18% | $178,977 |
| 2019 | 140 | 44 | None | None | $27,188 |
| 2018 | 199 | 106 | 17% (33) | None | $14,900 |
| 2017 | 250 | 118 | 16% (39) | 10% | $9,494 |
| 2016 | 116 | 59 | None | None | $6,853 |
| 2015 | 103 | 45 | None | None | $5,372 |
| 2014 | 31 | 15 | None | None | $2,949 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Cinacalcet | 26 | $22,576 | $868 |
| Lokelma | 22 | $17,712 | $805 |
| Valganciclovir | 23 | $8,131 | $354 |
| Tacrolimus | 42 | $7,479 | $178 |
| Carvedilol | 19 | $409 | $22 |
| Amlodipine Besylate | 27 | $385 | $14 |
| Hydralazine | 11 | $292 | $27 |
| Tamsulosin | 17 | $162 | $10 |
| Clonidine | 15 | $123 | $8 |
| Furosemide | 13 | $75 | $6 |
2022: 9 drugs
| Cinacalcet | 20 | $16,705 | $835 |
| Lokelma | 15 | $9,862 | $657 |
| Valganciclovir | 18 | $7,360 | $409 |
| Carvedilol | 39 | $421 | $11 |
| Nifedipine Er | 11 | $345 | $31 |
| Amlodipine Besylate | 49 | $317 | $6 |
| Furosemide | 30 | $181 | $6 |
| Clonidine | 13 | $168 | $13 |
| Sulfamethoxazole-Trimethoprim | 12 | $96 | $8 |
2021: 18 drugs
| Cinacalcet | 12 | $18,151 | $1,513 |
| Envarsus Xr | 12 | $10,180 | $848 |
| Eliquis | 13 | $9,656 | $743 |
| Valganciclovir | 13 | $5,287 | $407 |
| Nifedipine Er | 28 | $1,042 | $37 |
| Labetalol | 22 | $992 | $45 |
| Clonidine | 12 | $965 | $80 |
| Ultra-Fine Nano Pen Needle | 14 | $646 | $46 |
| Clonidine | 31 | $522 | $17 |
| Tamsulosin | 34 | $509 | $15 |
| Pantoprazole | 36 | $463 | $13 |
| Atorvastatin | 12 | $351 | $29 |
| Amlodipine Besylate | 32 | $342 | $11 |
| Prednisone | 42 | $254 | $6 |
| Carvedilol | 26 | $200 | $8 |
| Furosemide | 32 | $195 | $6 |
| Sulfamethoxazole-Trimethoprim | 15 | $124 | $8 |
| Omeprazole | 11 | $92 | $8 |
2020: 23 drugs
| Cinacalcet | 25 | $33,682 | $1,347 |
| Envarsus Xr | 26 | $28,254 | $1,087 |
| Valganciclovir | 29 | $18,060 | $623 |
| Eliquis | 16 | $11,569 | $723 |
| Mycophenolic Acid | 11 | $5,803 | $528 |
| Tacrolimus | 13 | $4,306 | $331 |
| Mycophenolate Mofetil | 16 | $795 | $50 |
| Labetalol | 16 | $581 | $36 |
| Nystatin | 11 | $580 | $53 |
| Hydralazine | 19 | $411 | $22 |
| Pantoprazole | 40 | $400 | $10 |
| Tamsulosin | 40 | $334 | $8 |
| Prednisone | 45 | $278 | $6 |
| Nifedipine Er | 16 | $252 | $16 |
| Amlodipine Besylate | 41 | $188 | $5 |
| Clonidine | 15 | $187 | $12 |
| Fludrocortisone Acetate | 15 | $179 | $12 |
| Furosemide | 24 | $142 | $6 |
| Atorvastatin | 14 | $133 | $9 |
| Rosuvastatin | 11 | $130 | $12 |
| Sulfamethoxazole-Trimethoprim | 27 | $122 | $5 |
| Carvedilol | 19 | $117 | $6 |
| Oxycodone | 11 | $57 | $5 |
2019: 4 drugs
| Valganciclovir | 16 | $19,319 | $1,207 |
| Nystatin | 17 | $1,221 | $72 |
| Sulfamethoxazole-Trimethoprim | 22 | $132 | $6 |
| Famotidine | 15 | $106 | $7 |
2018: 1 drug
| Prednisone | 18 | $62 | $3 |
2017: 5 drugs
| Amlodipine Besylate | 21 | $124 | $6 |
| Pantoprazole | 12 | $108 | $9 |
| Oxycodone | 13 | $92 | $7 |
| Levofloxacin | 13 | $87 | $7 |
| Prednisone | 21 | $67 | $3 |
Money from drug and device companies
$2,476 in 2025
| 2025 | 3 | 9 | $1,528 | $2,476 |
| 2022 | 1 | 1 | None | $61 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Veloxis Pharmaceuticals | Envarsus | $2,224 | 7 payments
|
| BeOne Medicines USA | Brukinsa | $143 | 1 payment
|
| Exelixis | Cabometyx | $109 | 1 payment
|
See all 9 published payments
| BeOne Medicines USA | Meals · 2025-12-03 | Brukinsa | $143 |
| Veloxis Pharmaceuticals | Consulting · 2025-11-20 | Envarsus | $1,528 |
| Veloxis Pharmaceuticals | Meals · 2025-11-04 | Envarsus | $119 |
| Exelixis | Meals · 2025-10-29 | Cabometyx | $109 |
| Veloxis Pharmaceuticals | Travel · 2025-10-27 | Envarsus | $288 |
| Veloxis Pharmaceuticals | Meals · 2025-10-25 | Envarsus | $71 |
| Veloxis Pharmaceuticals | Meals · 2025-10-25 | Envarsus | $60 |
| Veloxis Pharmaceuticals | Meals · 2025-10-25 | Envarsus | $60 |
| Veloxis Pharmaceuticals | Education · 2025-04-16 | None | $97 |
See earlier years (2022)
2022: $61
| Veloxis Pharmaceuticals | Envarsus | $61 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1184965592
- Licence
- CA 95016359, CA 95030420, NY 658268-1, NY F430805
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LA2100X (363LA2100X); Federal specialty code 163W00000X (163W00000X)
- Mailing address
- 400 Parnassus Ave Rm 701, San Francisco, CA, 94143
- NPI first listed
- 2013-03-11
- NPI last updated
- 2021-03-22
- NPI record certified
- 2021-03-22
This is when the NPI record was last certified, not a medical board exam.